Terns Pharmaceuticals, Inc. (TERN) - Company Total Revenue

Terns Pharmaceuticals (TERN) prospects are linked to the development of safe small molecules for the treatment of cancer and obesity, which will provide significant pricing power. The company's sales dynamics confirm the research stage, where the current value is 0.00. The absence of revenue makes the business dependent on investments, while the company strictly adheres to environmental regulations regarding the disposal of hazardous waste.

ternspharma.com (TERN) - Company Revenue from 07/04/2022 to 05/16/2026

Analytical breakdowns for Terns Pharmaceuticals Inc (TERN)

- share price and consensus valuation forecast:

Price Terns Pharmaceuticals|TERN - Analyst Consensus Forecast

- market capitalization indicators:

Market Value Terns Pharmaceuticals Inc|TERN - Total Company Value

- book value of equity indicators:

Accounting Value of a Share Terns Pharmaceuticals|TERN - Company Book Value|Capitalization to Book Value Ratio ternspharma.com|TERN - Aggregate Company Assets

- company liabilities and liquidity data:

Total Debt to Capital Coefficient Terns Pharmaceuticals|TERN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Terns Corp|TERN - Company Debts|Debts to Book Capitalization Ratio Terns Pharma|TERN - Company Long-Term Debts|Company Short-Term Loans and Borrowings Terns Pharmaceuticals|Quick Ratio ternspharma.com

- earnings and valuation multiples indicators:

TERN - Company Net Income|Expected Net Income Terns Pharmaceuticals|TERN - Price to Earnings Ratio|Projected Price to Earnings Terns Pharmaceuticals, Inc.|TERN - PEG Multiple|EV/EBITDA Multiple Terns Pharma|TERN - Operating profit EBITDA|Net earnings per share for the last 12 months Terns Pharmaceuticals|TERN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months ternspharma.com|TERN - Net earnings per share growth this year|Earnings growth forecast for next year Terns Pharmaceuticals

- sales volume and revenue indicators:

TERN - Company Sales|Company Projected Revenue Volume Terns Pharmaceuticals|TERN - P/S Multiple|Market Cap to Expected Sales Ratio Terns Pharma

Comprehensive company analysis:Terns Pharmaceuticals (TERN)

The indicator is based on the aggregation of daily operating revenue streams, excluding temporary reporting gaps. This metric measures the intensity of market demand, allowing for an assessment of the actual scale of product commercialization. For Terns Pharmaceuticals (TERN), this figure reflects the effectiveness of monetizing developments in the field of metabolic liver pathologies. Investors should correlate clinical stage funding with revenue dynamics. The positive sales trajectory of the company confirms business expansion.

Key competitors